Form 4: C3.ai Director Granted Stock Options

C3.ai Director D. Bruce Sewell received 30,264 stock options with a $19.16 exercise price, vesting over two years contingent on board meeting attendance.

Summary

• D. Bruce Sewell, a Director at C3.ai, Inc. (AI), was granted 30,264 stock options.
• The options have an exercise price of $19.16 per share.
• The transaction date and vesting commencement date is October 3, 2025.
• The options expire on October 2, 2035.
• Vesting occurs quarterly over two years, with 12.5% of shares vesting on the last day of each fiscal quarter, contingent on the director's in-person attendance at regularly scheduled board meetings.
• If attendance is missed, vesting for those quarterly shares is suspended but can occur after the two-year anniversary if subsequent attendance requirements are met.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally a positive event as it aligns management/director interests with shareholders. The specific vesting conditions tied to attendance further enhance governance. However, it is a routine disclosure and not indicative of significant operational or financial performance changes.

Positives

• Aligns the director's financial interests with those of shareholders through equity compensation.
• The vesting schedule, tied to board meeting attendance, incentivizes active participation and commitment from the director.

Risks

• The value of the options is subject to the future market price of C3.ai's Class A Common Stock, which may be below the exercise price.
• Vesting is contingent on the director's continued service and attendance at board meetings, meaning the full grant may not vest if conditions are not met.

Future Outlook

The filing details a future vesting schedule for stock options, contingent on the director's continued service and attendance at board meetings over the next two years, with an expiration date ten years from the grant.

Industry Context

This transaction represents a standard practice in corporate governance where directors receive equity compensation to align their long-term interests with those of the company's shareholders. Such grants are common across publicly traded companies, particularly in the technology sector, to attract and retain experienced board members.

Comparison to Industry Standards

• Granting stock options to non-employee directors is a common compensation practice, comparable to similar arrangements at companies like Palantir Technologies (PLTR) or Snowflake (SNOW) for their board members.
• The specific vesting schedule, tied to quarterly board meeting attendance over two years, is a governance mechanism designed to ensure active engagement, a practice seen in various forms across different corporate boards to promote director accountability.
• The exercise price of $19.16 is likely based on the market price of C3.ai's stock on the grant date, which is standard for incentive stock options.

Corporate Governance

Related Party Transactions

• The grant of stock options to D. Bruce Sewell, a director of C3.ai, Inc., constitutes a related party transaction. This is a standard form of compensation for non-employee directors, designed to align their interests with those of the company's shareholders.

Stakeholder Impact

• Shareholders: Benefits from increased alignment of director's interests with long-term company performance and incentivized active board participation.
• Director (D. Bruce Sewell): Receives equity compensation, providing a direct financial incentive tied to the company's stock performance and continued service.

Next Steps

• D. Bruce Sewell must attend regularly scheduled board meetings to ensure the quarterly vesting of the stock options.
• The company will continue to report any changes in beneficial ownership for D. Bruce Sewell via subsequent Form 4 filings.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a director as part of their compensation. While it positively aligns the director's interests with shareholders and includes a beneficial governance mechanism (attendance-based vesting), it does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard disclosure for insider transactions.

Keywords

C3.ai, AI, Form 4, stock options, insider transaction, director compensation, D. Bruce Sewell, equity grant, corporate governance